PMID- 26089885
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150619
LR  - 20240324
IS  - 1687-8337 (Print)
IS  - 1687-8345 (Electronic)
IS  - 1687-8337 (Linking)
VI  - 2015
DP  - 2015
TI  - Quality of Care for Patients with Type 2 Diabetes Mellitus in Dubai: A HEDIS-Like 
      Assessment.
PG  - 413276
LID - 10.1155/2015/413276 [doi]
LID - 413276
AB  - Objective. As little data are available on the quality of type 2 diabetes 
      mellitus (T2DM) care in the Arabian Gulf States, we estimated the proportion of 
      patients receiving recommended monitoring at the Dubai Hospital for T2DM over one 
      year. Methods. Charts from 150 adults with T2DM were systematically sampled and 
      quality of care was assessed during one calendar year, using a Healthcare 
      Effectiveness Data and Information Set- (HEDIS-) like assessment. Screening for 
      glycosylated haemoglobin (HbA1c), low-density lipoprotein (LDL), blood pressure, 
      retinopathy, and nephropathy was considered. Patients were classified based on 
      their most recent test in the period, and predictors of receiving quality care 
      were examined. Results. Mean age was 58 years (standard deviation (SD): 12.4 
      years) and 33% were males. Over the year, 98% underwent HbA1c screening (50% had 
      control and 28% displayed poor control); 91% underwent LDL screening (65% had 
      control); 55% had blood pressure control; 30% had retinopathy screening; and 22% 
      received attention for nephropathy. No individual characteristics examined 
      predicted receiving quality care. Conclusion. Some guideline monitoring was 
      conducted for most patients; and rates of monitoring for selected measures were 
      comparable to benchmarks from the United States. Greater understanding of factors 
      leading to high adherence would be useful for other areas of preventive care and 
      other jurisdictions.
FAU - Szabo, Shelagh M
AU  - Szabo SM
AD  - ICON Epidemiology, 450-688 W Hastings Street, Vancouver, BC, Canada V6B 1P1.
FAU - Osenenko, Katherine M
AU  - Osenenko KM
AD  - ICON Epidemiology, 450-688 W Hastings Street, Vancouver, BC, Canada V6B 1P1.
FAU - Qatami, Lara
AU  - Qatami L
AD  - Bristol-Myers Squibb, P.O. Box 454409, Dubai, UAE.
FAU - Korenblat Donato, Bonnie M
AU  - Korenblat Donato BM
AD  - Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA.
FAU - Korol, Ellen E
AU  - Korol EE
AD  - ICON Epidemiology, 450-688 W Hastings Street, Vancouver, BC, Canada V6B 1P1.
FAU - Al Madani, Abdulrazzaq A
AU  - Al Madani AA
AD  - Dubai Hospital, Al Khaleeja Street, Al Baraha, Dubai, UAE.
FAU - Al Awadi, Fatheya F
AU  - Al Awadi FF
AD  - Dubai Hospital, Al Khaleeja Street, Al Baraha, Dubai, UAE.
FAU - Al-Ansari, Jaber
AU  - Al-Ansari J
AD  - Dubai Hospital, Al Khaleeja Street, Al Baraha, Dubai, UAE.
FAU - Maclean, Ross
AU  - Maclean R
AD  - Precision Health Economics, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, 
      CA 90025, USA.
FAU - Levy, Adrian R
AU  - Levy AR
AD  - Department of Community Health and Epidemiology, Dalhousie University, 425-5790 
      University Avenue, Halifax, NS, Canada B3H 1V7.
LA  - eng
PT  - Journal Article
DEP - 20150524
PL  - Egypt
TA  - Int J Endocrinol
JT  - International journal of endocrinology
JID - 101516376
PMC - PMC4458297
EDAT- 2015/06/20 06:00
MHDA- 2015/06/20 06:01
PMCR- 2015/05/24
CRDT- 2015/06/20 06:00
PHST- 2015/02/03 00:00 [received]
PHST- 2015/04/24 00:00 [accepted]
PHST- 2015/06/20 06:00 [entrez]
PHST- 2015/06/20 06:00 [pubmed]
PHST- 2015/06/20 06:01 [medline]
PHST- 2015/05/24 00:00 [pmc-release]
AID - 10.1155/2015/413276 [doi]
PST - ppublish
SO  - Int J Endocrinol. 2015;2015:413276. doi: 10.1155/2015/413276. Epub 2015 May 24.